Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Upgrades
- Guggenheim upgraded the stock for Amneal Pharmaceuticals Inc (NYSE:AMRX) from Sell to Neutral. In the first quarter, Amneal Pharmaceuticals showed an EPS of $0.20, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $11.15 and a 52-week-low of $2.27. Amneal Pharmaceuticals's stock last closed at $4.56 per share.
- Wedbush upgraded the stock for CarMax Inc (NYSE:KMX) from Neutral to Outperform. CarMax earned $1.30 in the fourth quarter, compared to $1.13 in the year-ago quarter. The stock has a 52-week-high of $103.18 and a 52-week-low of $37.59. CarMax's stock last closed at $76.01 per share.
- CL King changed the rating for J&J Snack Foods Corp (NASDAQ:JJSF) from Neutral to Buy. J&J Snack Foods earned $0.38 in the second quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $196.84 and a 52-week-low of $105.67. J&J Snack Foods's stock last closed at $121.55 per share.
- For Pinnacle West Capital Corp (NYSE:PNW), Guggenheim upgraded the stock from Neutral to Buy. Pinnacle West Capital earned $0.27 in the first quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $105.51 and a 52-week-low of $60.05. Pinnacle West Capital's stock last closed at $73.67 per share.
- H.C. Wainwright upgraded the stock for Pulse Biosciences Inc (NASDAQ:PLSE) from Neutral to Buy. In the first quarter, Pulse Biosciences showed an EPS of ($0.57), compared to ($0.49) from the year-ago quarter. The stock has a 52-week-high of $17.45 and a 52-week-low of $5.11. Pulse Biosciences's stock last closed at $11.74 per share.
- Raymond James changed the rating for Uniti Group Inc (NASDAQ:UNIT) from Outperform to Strong Buy. Uniti Group earned $0.45 in the first quarter. The stock has a 52-week-high of $11.85 and a 52-week-low of $4.86. Uniti Group's stock last closed at $7.13 per share.
- Goldman Sachs upgraded the stock for Axalta Coating Systems Ltd (NYSE:AXTA) from Neutral to Buy. In the first quarter, Axalta Coating Sys showed an EPS of $0.31, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $32.20 and a 52-week-low of $12.92. Axalta Coating Sys's stock last closed at $19.63 per share.
- Raymond James changed the rating for CymaBay Therapeutics Inc (NASDAQ:CBAY) from Market Perform to Outperform. For the first quarter, CymaBay Therapeutics had an EPS of ($0.19), compared to year-ago quarter EPS of ($0.37). The stock has a 52-week-high of $13.32 and a 52-week-low of $1.21. CymaBay Therapeutics's stock last closed at $1.84 per share.
- HSBC upgraded the stock for Liberty Global PLC (NASDAQ:LBTYA) from Hold to Buy. In the first quarter, Liberty Global showed an EPS of $1.50, compared to ($0.43) from the year-ago quarter. The stock has a 52-week-high of $28.62 and a 52-week-low of $15.23. Liberty Global's stock last closed at $21.54 per share.
- Atlantic Equities changed the rating for Marsh & McLennan Companies Inc (NYSE:MMC) from Neutral to Overweight. Marsh & McLennan earned $1.64 in the first quarter, compared to $1.52 in the year-ago quarter. The stock has a 52-week-high of $119.88 and a 52-week-low of $74.33. Marsh & McLennan's stock last closed at $104.11 per share.
- Janney Capital upgraded the stock for Eversource Energy (NYSE:ES) from Neutral to Buy. In the first quarter, Eversource Energy showed an EPS of $1.02, compared to $0.97 from the year-ago quarter. The stock has a 52-week-high of $99.42 and a 52-week-low of $60.69. Eversource Energy's stock last closed at $77.01 per share.
Downgrades
- Jefferies downgraded the stock for Evelo Biosciences Inc (NASDAQ:EVLO) from Buy to Hold. In the first quarter, Evelo Biosciences showed an EPS of ($0.71), compared to ($0.64) from the year-ago quarter. The stock has a 52-week-high of $10.09 and a 52-week-low of $3.01. Evelo Biosciences's stock last closed at $5.48 per share.
- For Stanley Black & Decker Inc (NYSE:SWK), B of A Securities downgraded the stock from Buy to Neutral. Stanley Black & Decker earned $1.20 in the first quarter, compared to $1.42 in the year-ago quarter. The stock has a 52-week-high of $173.67 and a 52-week-low of $70.00. Stanley Black & Decker's stock last closed at $113.70 per share.
- Raymond James downgraded the stock for ON Semiconductor Corp (NASDAQ:ON) from Strong Buy to Outperform. In the first quarter, ON Semiconductor showed an EPS of $0.10, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $25.92 and a 52-week-low of $8.17. ON Semiconductor's stock last closed at $15.66 per share.
- Goldman Sachs changed the rating for Albemarle Corp (NYSE:ALB) from Buy to Neutral. Albemarle earned $1.00 in the first quarter, compared to $1.23 in the year-ago quarter. The stock has a 52-week-high of $99.40 and a 52-week-low of $48.89. Albemarle's stock last closed at $64.34 per share.
- Piper Sandler downgraded the stock for Cummins Inc (NYSE:CMI) from Overweight to Neutral. For the first quarter, Cummins had an EPS of $3.18, compared to year-ago quarter EPS of $4.20. The stock has a 52-week-high of $186.72 and a 52-week-low of $101.03. Cummins's stock last closed at $161.89 per share.
- Goldman Sachs downgraded the stock for CenterPoint Energy Inc (NYSE:CNP) from Buy to Neutral. CenterPoint Energy earned $0.65 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $30.71 and a 52-week-low of $11.58. CenterPoint Energy's stock last closed at $18.18 per share.
- Imperial Capital changed the rating for Continental Resources Inc (NYSE:CLR) from Outperform to In-Line. Continental Resources earned ($0.08) in the first quarter, compared to $0.58 in the year-ago quarter. The stock has a 52-week-high of $43.77 and a 52-week-low of $6.90. Continental Resources's stock last closed at $14.02 per share.
- UBS changed the rating for Chevron Corp (NYSE:CVX) from Buy to Neutral. Chevron earned $1.58 in the first quarter, compared to $1.39 in the year-ago quarter. The stock has a 52-week-high of $127.00 and a 52-week-low of $51.60. Chevron's stock last closed at $93.39 per share.
- For PACCAR Inc (NASDAQ:PCAR), Piper Sandler downgraded the stock from Overweight to Neutral. In the first quarter, PACCAR showed an EPS of $1.03, compared to $1.81 from the year-ago quarter. The stock has a 52-week-high of $83.41 and a 52-week-low of $49.11. PACCAR's stock last closed at $68.83 per share.
- For Portland General Electric Co (NYSE:POR), Mizuho downgraded the stock from Buy to Neutral. For the first quarter, Portland General Electric had an EPS of $0.91, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $63.08 and a 52-week-low of $37.83. Portland General Electric's stock last closed at $45.03 per share.
- For Quidel Corp (NASDAQ:QDEL), JP Morgan downgraded the stock from Neutral to Underweight. For the first quarter, Quidel had an EPS of $1.22, compared to year-ago quarter EPS of $0.91. The stock has a 52-week-high of $210.81 and a 52-week-low of $52.49. Quidel's stock last closed at $208.95 per share.
- Credit Suisse downgraded the stock for Williams Companies Inc (NYSE:WMB) from Outperform to Neutral. Williams Companies earned $0.26 in the first quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $29.06 and a 52-week-low of $8.41. Williams Companies's stock last closed at $19.53 per share.
- Piper Sandler downgraded the stock for Marker Therapeutics Inc (NASDAQ:MRKR) from Overweight to Neutral. In the first quarter, Marker Therapeutics earned ($0.14). The stock has a 52-week-high of $9.17 and a 52-week-low of $1.33. Marker Therapeutics's stock last closed at $2.48 per share.
Initiations
- Oppenheimer initiated coverage on Aldeyra Therapeutics Inc (NASDAQ:ALDX) with an Outperform rating. The price target for Aldeyra Therapeutics is set at $12.00. For the first quarter, Aldeyra Therapeutics had an EPS of ($0.34), compared to year-ago quarter EPS of ($0.33). The stock has a 52-week-high of $8.05 and a 52-week-low of $1.48. Aldeyra Therapeutics's stock last closed at $2.96 per share.
- Oppenheimer initiated coverage on Arvinas Inc (NASDAQ:ARVN) with a Perform rating. For the first quarter, Arvinas had an EPS of ($0.56), compared to year-ago quarter EPS of ($0.46). The stock has a 52-week-high of $58.00 and a 52-week-low of $15.19. Arvinas's stock last closed at $56.74 per share.
- Cantor Fitzgerald initiated coverage on Premier Inc (NASDAQ:PINC) with an Overweight rating. The price target for Premier is set at $42.00. In the third quarter, Premier showed an EPS of $0.73, compared to $0.66 from the year-ago quarter. The stock has a 52-week-high of $40.13 and a 52-week-low of $27.11. Premier's stock last closed at $30.65 per share.
- With a rating of Buy, Jefferies initiated coverage on TC Pipelines LP (NYSE:TCP). The price target is set at $39.00 for TC Pipelines. TC Pipelines earned $1.21 in the first quarter, compared to $1.28 in the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $18.00. TC Pipelines's stock last closed at $33.29 per share.
- Cowen & Co. initiated coverage on Cerence Inc (NASDAQ:CRNC) with an Outperform rating. The price target for Cerence is set at $28.00. Interestingly, in the second quarter, Cerence's EPS was $0.43. The stock has a 52-week-high of $27.28 and a 52-week-low of $11.39. Cerence's stock last closed at $23.85 per share.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!